Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by M&T Bank Corp

M&T Bank Corp raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 68,581 shares of the medical equipment provider’s stock after buying an additional 226 shares during the quarter. M&T Bank Corp’s holdings in Intuitive Surgical were worth $33,691,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of ISRG. Ridgewood Investments LLC purchased a new position in Intuitive Surgical during the second quarter worth about $26,000. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. LGT Financial Advisors LLC raised its stake in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last quarter. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $524.43 on Friday. The stock has a market capitalization of $186.79 billion, a P/E ratio of 84.31, a P/E/G ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 12-month low of $320.26 and a 12-month high of $556.23. The firm’s 50-day moving average is $526.84 and its two-hundred day moving average is $483.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research analyst reports. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.